MS
Malcolm Salter
Director

Malcolm Salter insider trades: C4 Therapeutics (CCCC) stock buys and sales

Director, C4 Therapeutics Last trade Dec 17, 2021 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2020
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Malcolm reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 17, 2021CCCC↓ Sell$23K
Nov 19, 2021CCCC↓ Sell$30K
Oct 15, 2021CCCC↓ Sell$34K
Sep 17, 2021CCCC↓ Sell$38K
Aug 20, 2021CCCC↓ Sell$31K
Jul 16, 2021CCCC↓ Sell$28K
Jun 18, 2021CCCC↓ Sell$28K
May 21, 2021CCCC↓ Sell$28K
Oct 6, 2020CCCC↑ Buy$25K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CCCC insiders

Open-market trades in the last 12 months

About Malcolm Salter's insider trades

Malcolm Salter is a director at C4 Therapeutics (CCCC). Since Oct 6, 2020, Malcolm has reported 1 open-market purchase worth $25K and 8 sales worth $240K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CCCC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.